Caricamento...
Rivastigmine improves dual-task gait velocity in patients with Alzheimer’s disease
BACKGROUND: Gait impairments are common in patients with Alzheimer’s disease. Cholinesterase inhibitors are used to treat the symptoms of patients with Alzheimer’s disease, but they have not been shown to reduce the severity of Alzheimer’s disease-related gait disorders. METHODS: This was a prospect...
Salvato in:
| Pubblicato in: | BMC Neurol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7874473/ https://ncbi.nlm.nih.gov/pubmed/33568083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-021-02098-8 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|